Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2015-12-31
2019-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Effects of Fats on Satiety & Energy Needs
NCT03236181
The Effect of Fatty Acid Composition on Energy Intake and Satiety
NCT00242021
Impact of High-fat Meals Varying in Fatty Acid Composition on Adipose and Systemic Metabolic-inflammatory Responses
NCT03712579
Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)
NCT03846908
The Influence of Fat Perception on Satiety From Consumption of Reduced Fat Snacks
NCT03585920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Saturated Fat (SFA)
30 grams saturated fat in the form of heavy whipping cream will be provided to subject in a smoothie drink
SFA
High saturated fatty acid/SFA oil source
Monounsaturated Fat (MUFA)
30 grams monounsaturated fat in the form of high oleic canola oil will be provided to subject in a smoothie drink
MUFA
High monounsaturated fatty acid/MUFA oil source
Polyunsaturated Fat Linoleic (PUFA-LA)
30 grams polyunsaturated fat in the form of high linoleic sunflower oil will be provided to subject in a smoothie drink
PUFA-LA
High polyunsaturated fatty acid (linoleic)/PUFA-LA oil source
Polyunsaturated Fat Alpha-Linolenic (ALA)
30 grams polyunsaturated fat in the form of flaxseed oil will be provided to subject in a smoothie drink
ALA
High polyunsaturated fatty acid (alpha-linolenic)/ALA oil source
Polyunsaturated Fat Long Chain Omega-3 (LCn3)
30 grams polyunsaturated fat in the form of fish oil (Coromega Omega3 Squeeze) will be provided to subject in a smoothie drink
LCn3
High polyunsaturated fatty acid (omega-3)/LCn3 oil source
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SFA
High saturated fatty acid/SFA oil source
MUFA
High monounsaturated fatty acid/MUFA oil source
PUFA-LA
High polyunsaturated fatty acid (linoleic)/PUFA-LA oil source
ALA
High polyunsaturated fatty acid (alpha-linolenic)/ALA oil source
LCn3
High polyunsaturated fatty acid (omega-3)/LCn3 oil source
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* free of major diagnosed, untreated medical conditions
* controlled hypertension
* non-smoking or use of other tobacco products, including e-cigarettes
* not taking steroid-based medications
* not planning to or currently attempting to gain or lose weight
* willing to comply with study demands
* use of oral contraceptives
* low intake of long chain omega 3 fatty acids
Exclusion Criteria
* diabetes (blood sugar ≥ 126 mg/dl)
* hypertension (systolic ≥ 160 mmHg or diastolic \> 100 mmHg)
* diagnosed cardiovascular, pulmonary, skeletal and metabolic disease
* currently pregnant or planning to become pregnant, or lactating
* taking medications known to affect appetite, blood lipids, body composition, body weight, or food intake (appetite control drugs, steroids, antidepressants)
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
USDA Grand Forks Human Nutrition Research Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Picklo, PhD
Role: PRINCIPAL_INVESTIGATOR
USDA Grand Forks Human Nutrition Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USDA Grand Forks Human Nutrition Research Center
Grand Forks, North Dakota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Grand Forks Human Nutrition Research Center Current Nutrition Studies
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFHNRC508
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.